Your session is about to expire
What is Acyclovir Sodium
AcyclovirThe Generic name of this drug
Treatment SummaryAcyclovir is a medication used to treat various types of viral infections, such as herpes simplex, Varicella zoster, herpes zoster, herpes labialis, and acute herpetic keratitis. It is the preferred treatment for these viruses and can be given to children as young as six years old. Acyclovir was approved by the FDA in 1982.
Zoviraxis the brand name
Acyclovir Sodium Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Zovirax
Acyclovir
1982
496
Effectiveness
How Acyclovir Sodium Affects PatientsAcyclovir helps to stop the spread of certain types of viruses by blocking their replication. It is generally considered to be a safe drug, as overdose is rare in healthy people.
How Acyclovir Sodium works in the bodyAcyclovir works by interfering with viral DNA. It is changed into a form that is more easily used by the virus. This form then binds to the virus's DNA polymerase and blocks it from functioning properly. The blocked enzymes prevent the virus from making copies of itself, which stops the infection from spreading.
When to interrupt dosage
The quantity of Acyclovir Sodium is contingent upon the specified condition, for instance Cytomegalovirus Infections, serious Genital herpes and Herpes simplex type I reactivation. The amount of dosage can be identified in the table below, in accordance with the method of administration (e.g. Cream - Topical or Injection, powder, lyophilized, for solution - Intravenous).Condition
Dosage
Administration
Herpes Labialis
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
prophylaxis of VZV re-activation
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Bone Marrow Transplant
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Neutropenia
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Keratitis, Herpetic
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Cytomegalovirus Infections
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
severe Genital herpes
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
VZV re-activation
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Herpes simplex type I reactivation
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Recurrent Herpes Labialis
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Genital Herpes
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
prophylaxis of HSV re-activation
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Genital Herpes
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Chickenpox
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Immunocompromised
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Encephalitis, Herpes Simplex
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Herpes Simplex Infections
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Shingles
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Bell's Palsy
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Communicable Diseases
200.0 mg, , 400.0 mg, 800.0 mg, 0.05 mg/mg, 200.0 mg/mL, 50.0 mg/mL, 100.0 mg/mL, 5.0 %, 500.0 mg, 1000.0 mg, 50.0 mg, 0.04 mg/mg, 0.03 mg/mg, 25.0 mg/mL
, Oral, Capsule, Capsule - Oral, Tablet, Tablet - Oral, Topical, Cream, Cream - Topical, Ointment, Ointment - Topical, Suspension, Suspension - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for solution, Powder, for solution - Intravenous, Solution, Solution - Intravenous, Buccal, Tablet, delayed release, Tablet, delayed release - Buccal, Ophthalmic, Ointment - Ophthalmic, Tablet - Buccal, Cutaneous, Ointment - Cutaneous, Kit, Kit - Oral; Topical, Oral; Topical
Warnings
Acyclovir Sodium ContraindicationsCondition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Acyclovir may interact with Pulse Frequency
Common Acyclovir Sodium Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The excretion of Abemaciclib can be decreased when combined with Acyclovir.
Neomycin
Major
The risk or severity of nephrotoxicity can be increased when Acyclovir is combined with Neomycin.
Procainamide
Major
The excretion of Procainamide can be decreased when combined with Acyclovir.
Tenofovir
Major
Acyclovir may increase the nephrotoxic activities of Tenofovir.
Tenofovir alafenamide
Major
Acyclovir may increase the nephrotoxic activities of Tenofovir alafenamide.
Acyclovir Sodium Toxicity & Overdose RiskAn overdose of Cytoxan may cause agitation, confusion, seizures, fatigue, and kidney deposits. These effects are more likely to occur when the drug is taken without monitoring of electrolyte and fluid levels or when kidney function is low. Treatment for an overdose includes providing supportive care and addressing any symptoms that arise.
Acyclovir Sodium Novel Uses: Which Conditions Have a Clinical Trial Featuring Acyclovir Sodium?
34 active investigations are examining the utility of Acyclovir Sodium in prophylactically thwarting VZV reactivation, Immunocompromised states and Communicable Diseases.Condition
Clinical Trials
Trial Phases
prophylaxis of HSV re-activation
0 Actively Recruiting
prophylaxis of VZV re-activation
0 Actively Recruiting
VZV re-activation
0 Actively Recruiting
Neutropenia
14 Actively Recruiting
Phase 3, Phase 1, Phase 2, Not Applicable, Phase 4
Genital Herpes
0 Actively Recruiting
Encephalitis, Herpes Simplex
0 Actively Recruiting
Communicable Diseases
1 Actively Recruiting
Phase 3
Chickenpox
3 Actively Recruiting
Phase 2, Phase 1
Herpes Simplex Infections
0 Actively Recruiting
Keratitis, Herpetic
0 Actively Recruiting
Shingles
14 Actively Recruiting
Phase 4, Phase 2, Phase 3, Phase 1, Not Applicable
Cytomegalovirus Infections
6 Actively Recruiting
Phase 2, Phase 1, Not Applicable
Cytomegalovirus Infections
0 Actively Recruiting
Herpes simplex type I reactivation
0 Actively Recruiting
Bone Marrow Transplant
23 Actively Recruiting
Not Applicable, Phase 2, Early Phase 1, Phase 1
Immunocompromised
4 Actively Recruiting
Phase 3, Not Applicable, Phase 1
Herpes Labialis
0 Actively Recruiting
Genital Herpes
0 Actively Recruiting
Recurrent Herpes Labialis
1 Actively Recruiting
Phase 3
Bell's Palsy
0 Actively Recruiting
Acyclovir Sodium Reviews: What are patients saying about Acyclovir Sodium?
5Patient Review
6/5/2014 I was given this medication in the ER for a severe headache and numbness on my right side. However, it caused a lot of other problems, some of which were worse than what I came in with. The most serious one that I found out about the day after they admitted me was kidney failure. My kidney function was down to 28%. They say it should come back, but now I'm stuck in the hospital until my numbers go down. DO NOT USE THIS DRUG! Two other people had the same complications that night in the ER and they stopped using it.
5Patient Review
8/26/2017 I went to the ER and was diagnosed with herpes zoster of cerebrospinal fluid. I was immediately put on this medication and it completely cleared up within three days.
5Patient Review
2/6/2016 This drug completely saved my life when I was admitted to the hospital with a systemic HSV-1 infection. I had meningitis and encephalitis caused by HSV-1, but after using this treatment, I dramatically improved.
3.7Patient Review
1/18/2009 I was treated with this medication for viral meningitis. I had to stay in the hospital for ten days, and then had three more at-home with a health professional. Unfortunately, I experienced bad hallucinations and gross hematuria (blood in urine) that led to me being readmitted for another week. Even now, my urine shows microscopic amounts of blood. I was told by three different doctors that this was a side effect of the medication.
2Patient Review
4/28/2008Patient Q&A Section about acyclovir sodium
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is acyclovir sodium used for?
"This medication can help treat outbreaks of herpes simplex infection on the skin, in mucous membrane areas, or in the brain. It can also help treat shingles infection."
Answered by AI
What should you not do while taking acyclovir?
"What should you avoid while taking acyclovir?
Do not take this medicine with any of the following medications:
valacyclovir.
This medicine may also interact with the following medications:
bosutinib.
chloramphenicol.
dicumarol.
female hormones, like estrogens or progestins and birth control pills, patches, rings, implants, or injections.
What are the bad side effects of acyclovir?
Common (1% to 10%): malaise, conjunctivitis, photosensitivity reaction, vertigo, tremor, headache. Rare (0.01% to 0.1%): seizure, status epilepticus. Frequency not reported: acute angle-closure glaucoma, auditory hallucinations, abnormal electroencephalogram (EEG), neuropathy, neuropsychiatric symptoms/reactions8 мая 2020 г.
What types of drugs are antiviral?
What Antiviral Medications Treat Influenza?
amantadine (Symmetrel)
rimantadine (Flumadine"
Answered by AI
Can you take acyclovir everyday?
"This medication is typically taken 2-5 times per day for 5-10 days, starting as soon as possible after symptoms start. When taken to prevent genital herpes outbreaks, it is usually taken 2-5 times per day for up to 12 months."
Answered by AI